The team behind Synagen
Synagen was founded in July 2024 by four physicians. Today the company brings together oncology, hematology, radiology, computational pathology, software engineering and data science – all working on the same problem: taking manual documentation work off oncology teams.
Dyke Ferber
Physician, previously at NCT Heidelberg and EKFZ Dresden. Leads research and development at Synagen.
LinkedIn ↗
Dr. Gandolf Finke
An engineer by training (KIT, ETH Zurich, MIT) and former McKinsey consultant, Gandolf co-founded the oncology platform Mika and leads strategy, regulatory affairs and commercialisation.
LinkedIn ↗
Dr. med. Christiane Höper
A physician with clinical oncology experience at NCT Heidelberg and Medical Affairs Oncology at AstraZeneca, Christiane leads medical, clinical evidence and partnerships.
LinkedIn ↗
Balaji Ramamurthy
A product leader with an MS in computer science, Balaji has built and scaled digital health products at companies including Ada Health and Vivy.
LinkedIn ↗
Prof. Dr. med. Jakob Kather
Professor of Clinical AI and physician-scientist developing AI for precision medicine and clinical decision-making.
LinkedIn ↗
Dr. med. Moritz Middeke
Hematologist and clinician-scientist translating AI into diagnostic and clinical workflows in oncology.
LinkedIn ↗
Prof. Dr. med. Daniel Truhn
Professor, physician and physicist developing multimodal and generative AI for real-world clinical applications.
LinkedIn ↗Working at Synagen
We are growing, in Berlin and Dresden. If you work in oncology, software engineering or data science and want to work on this problem, get in touch.